Schedule an introductory call today!

+31 (0) 629075858

RegPak BioPharma Consulting

RegPak BioPharma Consulting (RegPak) is a full-service consulting company based in The Netherlands and Romania. RegPak offers a consultancy that adapts to new demands, business pressures with understanding of clients’ current and future needs.

RegPak high quality consultancy services include a Strategic Planning offering that assists clients to develop new products, speed regulatory approval and reduce time to market. 

RegPak applies its expertise in practical and logical ways to help companies worldwide, continually striving for excellence and sharing its principles and practices through training, presentations and publications. It develops services and creative offerings that provide new and more efficient ways for clients, their vendors, suppliers, and service providers to conduct their businesses within regulatory compliance and with reduced risk. 

RegPak approach is interdisciplinary, with a strong emphasis on the science underlying the product. It also prioritizes client confidentiality and assured security of data. As an independent organization, RegPak avoids all conflicts of interest.

The service leverages RegPak’s expertise
in many therapeutic areas:

oncology

autoimmune diseases

cardiovascular

CNS

dermatology

infectious diseases

It includes all the key expertise and processes required to satisfy regulatory requirements and smooth the way to market approval for biologicals (including biosimilars), vaccines, small molecules, generics, cosmeceuticals, nutraceutical/herbal products and medical devices. RegPak’s Expertise:

  • Regulatory intelligence & expert knowledge of global regulatory requirements
  • Clinical Trial Monitoring Support for BioPharma& Medical Device Companies
  • Pharmacovigilance
  • Product Promotion & Labelling
  • QA & Inspections
  • Due Diligence
  • Pricing and Reimbursement
  • Technical Writing

Contact us

Aristotelesstraat 16, 1064 LD, Amsterdam

RO Address: Bulevardul Unirii 11, Bloc 2B, Sector 4, Bucharest

Tele-Fax : +31 (0) 207729539

Phone: +31 6290 75858


Email: info@regpakbiopharma.com

bd@regpakbiopharma.com

Website: regpakbiopharma.com

LEARN MORE

Go to article: Home | Once more unto the (data) breachGo to article: In this issueGo to article: ContentsGo to article: SHL MedicalGo to article: SHL Medical Company Insight Go to article: Datwyler Company InsightGo to article: DatwylerGo to article: LabcorpGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: BaxterGo to article: Sukano Company InsightGo to article: SukanoGo to article: CommentGo to article: Use of off-label therapies increases the need for reliable clinical trial dataGo to article: Unmet needs remain in the neuroendocrine tumour treatment paradigmGo to article: Drinking alcohol raises risk of oesophageal and other cancersGo to article: Verder Company InsightGo to article: VerderGo to article: RegPakGo to article: Avery DennisonGo to article: In DepthGo to article: Pharma cybersecurity breaches to know and learn fromGo to article: The drugs treating alcoholism Go to article: In with the old: how an established vaccine is fuelling Covid-19 treatmentGo to article: How are hospitals tackling pharmaceutical pollution?Go to article: After Covid-19, mRNA technology aims to revolutionise the flu shotGo to article: Pushing for a UK genomics revolutionGo to article: MicronovaGo to article: Pfeiffer VacuumGo to article: HOF SonderanlagenbauGo to article: In DataGo to article: Data: pharma subsidiaries Go to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue